Showing 241-250 of 6901 results for "".
Highlights From the Omnia/Prova Collaborative Educational Conference in New York
https://reachmd.com/programs/conference-coverage/highlights-from-the-omniaprova-collaborative-educational-conference-in-new-york/6702/Omnia Education's and Prova Education's combined Capstone Conference in New York took advantage of common interests across all learners, addressing clinical trends and future directions across a broad spectrum of primary care and women's health topics. Joining host Lawrence Sherman to reflect on higShould We Add ECG to Routine Screening of Young Athletes?
https://reachmd.com/programs/heart-matters/should-we-add-ecg-to-routine-screening-of-young-athletes/5826/Sudden cardiac death among high school or college athletes is rare but tragic, and is jarring to families, friends and communities. What additional measures can physicians take to prevent sudden cardiac death among these students? Current guidelines for screening of young athletes in the U.S. do notAsk the Neurologist: Dr. Samuels Answers Your Questions
https://reachmd.com/programs/inspired-to-act/ask-the-neurologist-dr-samuels-answers-your-questions-1/5427/Host Dr. Martin A. Samuels, neurologist-in-chief and chairman of the department of neurology at Brigham and Women's Hospital, and professor of neurology at Harvard Medical School, answers your questions about promising therapies for ALS, the role of exercise for Parkinson's disease patients, sleepHow Well Do You Know Your Brain?
https://reachmd.com/programs/clinicians-roundtable/how-well-do-you-know-your-brain/3022/Our patients use their brains every moment of their lives. So do we! How well do you know your brain? You may be distressed at the answer. Dr. Sandra Aamodt, co-author along with Dr. Sam Wang of Welcome to Your Brain joins host Dr. Leslie Lundt to discuss common misconceptions about neurobiology.A Young Iraqi Girl Endures After Complex Heart Surgery
https://reachmd.com/programs/clinicians-roundtable/a-young-iraqi-girl-endures-after-complex-heart-surgery/2611/Despite the tremendous conflict in Iraq, there have been many medical miracles. One such story centers around Amenah Al-Bayati, a young Iraqi girl found ill by a United States Marine Corps battalion surgeon, who suspected the girl had a potentially life-threatening heart condition, fixable only by iToo Young to Feel Old: The Arthritis Doctor's 28-Day Formula for Pain-Free Living
https://reachmd.com/programs/clinicians-roundtable/too-young-to-feel-old-arthritis-doctors-28-day-formula-pain-free-living/2462/Dr. Richard H. Blau is the founder and Medical Director of The Arthritis Institute of Long Island in Long Island, New York and a Founding Fellow of the American College of Rheumatology. Hear Dr. Blau as he discusses his book, Too Young to Feel Old: The Arthritis Doctor's 28-Day Formula for Pain-FreeHave your adult patients been vaccinated?
https://reachmd.com/programs/clinicians-roundtable/have-your-adult-patients-been-vaccinated/1761/Pertussis is on the rise in adults. Are your patients protected? Find out about available adult vaccinations for pertussis and other diseases from our guest Dr. William Schaffner of the National Foundation for Infectious Disease.Improving Communication In Your Practice - 2
https://reachmd.com/programs/clinicians-roundtable/improving-communication-in-your-practice-2/441/Dr. Germain continues her discussion on effective staff communication within your medical practice.Outcomes for PDR Patients LTFU for at Least 1 Year
https://reachmd.com/programs/new-retina-radio/outcomes-for-pdr-patients-ltfu-for-at-least-1-year/48969/How did patients with PDR fare after being lost to follow-up for at least 1 year and then returning to the clinic? Kyle Kovacs, MD, is joined by Matt Starr, MD, and Nita Valikodath, MD, MS, to explore a recent paper that leveraged the power the IRIS Registry to assess real-world outcomes for this imAdjuvant Nivolumab in High-Risk Muscle Invasive Urothelial Carcinoma: 5-Year Data
https://reachmd.com/programs/project-oncology/adjuvant-nivolumab-in-high-risk-muscle-invasive-urothelial-carcinoma/36306/Five years after treatment, the impact of adjuvant nivolumab still holds strong in high-risk muscle invasive urothelial carcinoma. Join Drs. Brian McDonough and Matthew Galsky as they review the CheckMate 274 trial’s long-term data, which show sustained disease-free survival and highlight ctDNA’s po